PharmaIN is a development stage biopharmaceutical company focused on enabling and improving injectable therapeutics based on the Protected Graft Copolymer (PGC™), our patented and proprietary drug delivery technology licensed from Massachusetts General Hospital. We are focused on half-life extension and targeted delivery of proteins, peptides, siRNA, and potent small molecule therapeutics.

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group. Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification. Philochem has discovered and development innovative methodologies in the following areas: - design, construction and screening of DNA-encoded chemical libraries of unprecedented quality and size - development of small molecule-drug conjugates for cancer therapy - development of radiolabeled ligands for cancer imaging - development and application of chemical proteomics methodologies for the discovery of pharmaceutical targets - mass spectrometric characterization of MHC peptidomes for the development of innovative immunomodulatory strategies These technologies are integrated into drug discovery and product development programs.

The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and\nother related life-threatening illnesses.

Yantai Lannacheng Biotechnology Co., Ltd., established on 2021-01-06, Business scope includes licensed projects:Drug Clinical Trial Services;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;marketing planning;Import and export;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Xi'an Libang Zhaoxin Biotechnology Co., Ltd., established on 2012-03-13, Business scope includes general business items:medicine,nutritious food,cosmeceuticals,pesticide,veterinary medicine,chemical industry,Research and development of coating related technologies,Technical Services,technical consulting,technology transfer;Import and export of goods and technology(Except for the import and export of goods and technologies prohibited and restricted by the state).(The above business scope excludes the special control and pre-licensing items stipulated by the state)

Shenyang Xinkang Pharmaceutical Research Co., Ltd., established on 2020-06-05, Business scope includes licensed projects:Inspection and testing service,Pharmaceutical commissioned production,Drug Wholesale,Drug retail,food production,food business,Health food production,Health food sales,Production of formula food for special medical purpose,Sales of formula food for special medical purposes(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Natural science research and experimental development,New material technology research and development,Technology intermediary service,The above-mentioned production is limited to branch operations(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kaihui Technology Development (Shanghai) Co., Ltd., established on 2006-07-13, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);New material technology research and development;Engineering and Technology Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Stago is a pharmaceutical company with a strong interest in clinical pathology and in Haemostasis. Stago develops and markets automated systems for blood analysis in coagulation.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Wuhan Baiqiang Biomedical Co., Ltd., established on 2018-01-05, Business scope includes technology development in the field of biotechnology,technical consulting;Pharmaceutical research and development, wholesale and retail;Chemical Products(Does not contain dangerous goods)R & D and wholesale and retail.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Suzhou Nagonos Biotechnology Co., Ltd., established on 2017-07-06, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Mimei Biotechnology Co., Ltd., established on 2019-09-25, Business scope includes licensed projects:Food additive production;Cosmetic production;Health food sales;Health food production;pharmaceutical production;Drug Wholesale;Drug import and export;Drug retail;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Additive Sales;Cosmetics Wholesale;Manufacturing of medical packaging materials;R&D of industrial enzyme preparations.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Hainan Poly Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The firm is specialized in injections and oral solid formulations. Its products include injection, oral solid dosage, dry suspension and active pharmaceutical ingredient (API). The company was founded by Min Hua Fan on July 14, 1992 and is headquartered in Haikou, China.